WELL Health Technologies (TSE:WELL) Announces Earnings Results

WELL Health Technologies (TSE:WELL) issued its quarterly earnings results on Monday. The company reported C$0.11 EPS for the quarter, FiscalAI reports. WELL Health Technologies had a net margin of 0.25% and a return on equity of 0.44%. The business had revenue of C$407.40 million for the quarter.

Here are the key takeaways from WELL Health Technologies’ conference call:

• Canadian Clinics reached a CAD 100 million annualized adjusted EBITDA run rate one quarter ahead of schedule. Q3 revenue grew 49%, adjusted EBITDA rose 82%, and same-clinic sales increased 12%, with management citing stronger margins and productivity.
• On a normalized basis, Q3 revenue increased 17% to CAD 407.4 million and adjusted EBITDA rose 20% to CAD 50.9 million, as growth shifted toward higher-margin businesses. Comparisons exclude CAD 17.6 million of Circle Medical revenue deferrals in the prior-year quarter.
• WELL updated 2026 revenue guidance to approximately CAD 1.58 billion, citing acquisition timing, slower second-half M&A, and weakness in U.S. provider staffing. It maintained adjusted EBITDA guidance of CAD 185 million to CAD 195 million.
• The WELLSTAR listing converted about CAD 155 million of preferred-share liabilities into equity, while a CAD 150 million bond offering helped repay convertible debentures and extend maturities to 2031, improving balance-sheet flexibility.
• WELL reported a CAD 135.5 million net loss, including CAD 67.5 million of non-cash impairments and WELLSTAR transaction-related charges; adjusted free cash flow attributable to shareholders was CAD 13.3 million, down from CAD 15.1 million. Management said two of three U.S. asset-sale processes had advanced with focused counterparties, but no binding outcomes were announced.

WELL Health Technologies Trading Down 15.5%

Shares of WELL stock opened at C$3.59 on Wednesday. The business has a 50-day moving average of C$4.23 and a 200 day moving average of C$4.19. The company has a debt-to-equity ratio of 100.05, a current ratio of 0.80 and a quick ratio of 1.02. WELL Health Technologies has a 1-year low of C$3.58 and a 1-year high of C$5.19. The stock has a market capitalization of C$918.85 million, a PE ratio of 179.50, a P/E/G ratio of -1.93 and a beta of 0.51.

Wall Street Analysts Forecast Growth

Separately, TD set a C$8.50 target price on shares of WELL Health Technologies and gave the company a “buy” rating in a report on Monday, October 5th. Five analysts have rated the stock with a Buy rating. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of C$7.40.

About WELL Health Technologies

WELL Health Technologies Corp. (TSX: WELL) is Canada’s largest outpatient healthcare company and a leading provider of technology-enabled healthcare solutions. WELL is building the infrastructure for a healthier Canada, where every patient gets better care, every provider is empowered by AI, and every piece of health data is protected. WELL owns and operates more than 250 clinics in Canada, supporting more than 5 million annual patient visits. Through its subsidiary WELLSTAR, WELL provides electronic medical records, AI-powered clinical tools, patient engagement platforms and IT management services.